💡Key takeaways
1️⃣ Mounjaro has recently been approved by the NHS for weight management and type 2 diabetes.
2️⃣ The phased rollout of Mounjaro means not everyone will have immediate access.
3️⃣ NHS cost for Mounjaro: £122 per month for the maximum maintenance dose.
4️⃣ Private clinics also offer Mounjaro, but prices may vary.
5️⃣ Understanding eligibility criteria can help you plan your access.
Mounjaro in the UK: what you need to know
Mounjaro (tirzepatide) has become one of the most talked-about medications for weight loss and diabetes management in the UK. With its dual function as a weight-loss aid and diabetes medication, it’s no surprise that both patients and healthcare professionals are eager to understand how to access it.
What Is Mounjaro?
Mounjaro is a GLP-1 receptor agonist that helps regulate blood sugar levels and suppress appetite, making it a powerful tool for weight loss. Originally developed for managing type 2 diabetes, it gained approval from the National Institute for Health and Care Excellence (NICE) in December 2024 for obesity management.
Availability: NHS vs. Private Clinics
As of March 2025, Mounjaro is available through the NHS, but the rollout is phased. Initially, it will be accessible to patients with a Body Mass Index (BMI) over 35 who also have at least one obesity-related health condition, such as type 2 diabetes or heart disease. The priority is given to those with the highest clinical need through specialist weight-management services, with general practice access expanding over the next decade.
For those not eligible for NHS prescriptions, private healthcare remains an option. While prices may vary between private clinics, it’s essential to verify the clinic’s credibility and the quality of care provided.
👉 Learn more about treatments at Lotus Weight Loss
Understanding Mounjaro pricing and the NHS rollout
Why Is the Rollout Taking So Long?
The NHS has implemented a phased rollout to manage the anticipated high demand. An estimated 3.4 million people in England may qualify for Mounjaro, making it essential to prioritize those with the greatest clinical need. Initial distribution will occur through specialist weight-management services, and broader access could take up to 12 years.
Cost Breakdown: NHS and Private
NHS Pricing:
Patients prescribed Mounjaro via the NHS will pay £122 per month if on the maximum maintenance dose (15 mg per week). For those not exempt from prescription charges, there’s an additional £9.65 per item fee. The estimated annual expenditure for the NHS on Mounjaro, including associated care, could reach £317.2 million by the third year of rollout.
Private Clinic Pricing:
Prices in the private sector are typically higher, reflecting both the cost of the medication and the associated care. Some clinics offer packages that include lifestyle support, dietary advice, and monitoring.
Why the Price Variation?
Several factors influence private pricing, including clinic location, additional services, and the provider’s operational costs. Always compare options and ensure that the clinic adheres to medical guidelines.
👉 Explore our pricing at Lotus Weight Loss
Practical tips for accessing Mounjaro in the UK

Check Your Eligibility:
Make sure you meet the NHS criteria: a BMI over 35 and at least one obesity-related health condition. This will significantly impact whether you can access Mounjaro through the NHS or need to consider private options.
Stay Updated on Rollout Progress:
Given the lengthy rollout period, staying informed through NHS updates and reputable healthcare sources will help you know when and where you can access Mounjaro.
👉 Visit our News & Insights for updates
Consider Private Options if Necessary:
If you do not meet the NHS criteria or want quicker access, look into private clinics. Verify the clinic’s reputation and ensure they follow best practices for weight management.
Explore Loyalty Programs:
Some clinics, like Lotus Weight Loss, offer loyalty points that can make long-term treatment more affordable.
👉 Learn about Lotus Loyalty Points
Consult Your GP:
Before starting any new weight-loss medication, discuss it with your GP or a specialist to ensure it’s safe and appropriate for your health needs.
Conclusion
Understanding the cost and availability of Mounjaro in the UK can feel overwhelming, but with the right information and planning, you can navigate the options effectively. Whether through the NHS or private clinics, being proactive and informed will ensure you make the best decision for your health.
Frequently Asked Questions
Is Mounjaro available on the NHS?
Yes, Mounjaro was approved for obesity management in December 2024, but access is limited and phased over 12 years.
How much does Mounjaro cost privately?
Prices vary but are generally higher than NHS prescriptions due to additional services.
Can I get Mounjaro without a prescription?
No, Mounjaro is a prescription-only medication, whether through the NHS or privately.
What if I don’t meet the NHS criteria?
Private healthcare options are available, though costs are higher. Always consult your GP for advice.
Are there alternative weight-loss injections to Mounjaro?
Yes, other options include Wegovy and Ozempic. Consult with a specialist to determine the best choice.
References
https://www.nice.org.uk/news/articles/nice-describes-how-weight-loss-drug-tirzepatide-will-be-rolled-out
https://www.bbc.co.uk/news/articles/cx2y5zl99vro
https://www.diabetes.org.uk/about-us/news-and-views/nice-approve-tirzepatide-mounjaro-treating-obesity-access-be-rolled-out
https://clinic.morrisons.com/weight-loss-service/mounjaro
https://dmd-browser.nhsbsa.nhs.uk/ampp/view/196910
https://www.bmj.com/content/385/bmj.q1239
https://www.gov.uk/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss
https://www.gov.uk/government/news/four-dose-mounjaro-kwikpen-approved-by-mhra-for-diabetes-and-weight-management
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104524/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242486/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069496/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558985/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045126/
https://www.nice.org.uk/news/articles/consultation-on-nhs-england-proposals-for-a-phased-launch-of-obesity-injection
https://commonslibrary.parliament.uk/research-briefings/cbp-10171/